- Result of AGM
- Holding(s) in Company
- Notice of AGM & Annual Report & Accounts
- Final Results
- Realisation-c£1.5m on sale of shares in Incanthera
- IMMUPHARMA AT BIO-EQUITY 2024 12-14 May
- Grant of Share Options
- New intellectual property strategy initiated
- Incanthera provides Comm'l Update/Revenue F'casts
- Grant of Share Options
More ▼
Key statistics
On Monday, ImmuPharma PLC (IMM:LSE) closed at 1.87, 126.89% above the 52 week low of 0.822 set on Mar 04, 2024.
52-week range
Short selling activityProvided by S&P Global Market Intelligence
Open | 1.85 |
---|---|
High | 1.90 |
Low | 1.85 |
Bid | 1.85 |
Offer | 1.89 |
Previous close | 1.89 |
Average volume | 1.19m |
---|---|
Shares outstanding | 416.44m |
Free float | 237.37m |
P/E (TTM) | -- |
Market cap | 7.71m GBP |
EPS (TTM) | -0.0081 GBP |
Data delayed at least 20 minutes, as of Jul 22 2024 15:12 BST.
More ▼